AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™

Clinical trial NCT00058747 · TERMINATED

Trial details

NCT number: NCT00058747
Sponsor: Agenus Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Chronic

Start date: 2003-03-01
Primary completion: 2006-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.